KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Cash from Operations: 2009-2024

Historic Cash from Operations for Exact Sciences (EXAS) over the last 16 years, with Dec 2024 value amounting to $210.5 million.

  • Exact Sciences' Cash from Operations rose 58.54% to $219.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $386.8 million, marking a year-over-year increase of 66.00%. This contributed to the annual value of $210.5 million for FY2024, which is 34.86% up from last year.
  • Per Exact Sciences' latest filing, its Cash from Operations stood at $210.5 million for FY2024, which was up 34.86% from $156.1 million recorded in FY2023.
  • In the past 5 years, Exact Sciences' Cash from Operations registered a high of $210.5 million during FY2024, and its lowest value of -$223.6 million during FY2022.
  • For the 3-year period, Exact Sciences' Cash from Operations averaged around $47.7 million, with its median value being $156.1 million (2023).
  • Per our database at Business Quant, Exact Sciences' Cash from Operations spiked by 222.24% in 2020 and then plummeted by 174.91% in 2021.
  • Over the past 5 years, Exact Sciences' Cash from Operations (Yearly) stood at $136.5 million in 2020, then crashed by 174.91% to -$102.2 million in 2021, then tumbled by 118.67% to -$223.6 million in 2022, then surged by 169.83% to $156.1 million in 2023, then soared by 34.86% to $210.5 million in 2024.